The Role of 24-Month Progression-Free Survival (PFS24) in the Long-Term Evaluation of Patients with Diffuse Large B Cell Lymphoma (DLBCL): A Real-World Single Center Study.
Hematological oncology（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要